Journal Articles
Progressive Multiple Sclerosis
This article provides an update on progressive forms of multiple sclerosis (MS) commonly referred to as primary progressive MS and secondary progressive MS. It discusses the importance of diagnosing and detecting progression early, the similarities between progressive forms, challenges in detecting progression, factors that could augment progression, and the importance of disease-modifying therapies in patients with evidence of active progressive MS. It also discusses the overall care of progressiveMS.
Read MoreEffectiveness of Aquatic Therapy for Individuals With Multiple Sclerosis: A Systematic Review
Multiple sclerosis (MS) is an inflammatory, demyelinating disease that attacks the central nervous system. It is estimated that from 350,000 to 400,000 people in the United States are affected by MS. This study is a systematic review of randomized controlled trials (RCTs) evaluating the benefits of aquatic therapy for people with MS.
Read More
MS and HIV or other immunocompromised patients
Avindra (Avi) Nath is the Clinical Director and the Chief of the Section of Infections of the Nervous System at the National Institute of Neurological Disorders and Stroke at NIH, positions he has held since 2011. Prior to this he was Professor of Neurology and Director of the Division of Neuroimmunology at Johns Hopkins University. He was previously the President of the International Society of Neurovirology. He conducts clinical and bench research on understanding the mechanisms by which viruses affect the brain and develop new methods for diagnosis and treatment of these infections.
Read More
MS and Immunizations
Hear from Gretchen LaSalle, MD FAAFP as she discusses multiple scleroris and immunziations.
Read MorePredicting Disability Worsening in Relapsing and Progressive Multiple Sclerosis
Multiple sclerosis (MS) is a clinically heterogeneous disease, which complicates expectant management as well as treatment decisions. This review provides an overview of both well established and emerging predictors of disability worsening, including clinical factors, imaging factors, biomarkers and treatment strategies.
Read MoreCOVID-19 among Patients with Multiple Sclerosis
We systematically reviewed the literature on COVID-19 in patients with multiple sclerosis (MS). We searched PubMed, Scopus, EMBASE, CINAHL, Web of Science, Google Scholar, and World Health Organization database from December 1, 2019, to December 18, 2020. Three conference abstract databases were also searched. We included any types of studies that reported characteristics of patients with MS with COVID-19.
Read More